Ines Nikolovski
YOU?
Author Swipe
View article: Improving ovarian cancer segmentation accuracy with transformers through AI-guided labeling
Improving ovarian cancer segmentation accuracy with transformers through AI-guided labeling Open
Transformer models have demonstrated the capability to produce highly accurate segmentation of organs and tumors. However, model training requires high-quality curated datasets to ensure robust generalization to unseen datasets. Hence, we …
View article: The Prevalence and Radiologic Features of Renal Cancers Associated with <i>FLCN, BAP1, SDH</i>, and <i>MET</i> Germline Mutations
The Prevalence and Radiologic Features of Renal Cancers Associated with <i>FLCN, BAP1, SDH</i>, and <i>MET</i> Germline Mutations Open
Purpose To investigate the prevalence of FLCN, BAP1, SDH, and MET mutations in an oncologic cohort and determine the prevalence, clinical features, and imaging features of renal cell carcinoma (RCC) associated with these muta…
View article: Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician Satisfaction
Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician Satisfaction Open
BACKGROUND. Imaging reports that consistently document all disease sites with a potential to increase surgical complexity or morbidity can facilitate ovarian cancer treatment planning. OBJECTIVE. The aims of this study were t…
View article: Supplementary Figures from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Supplementary Figures from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma Open
Supplementary Figures S1 and S2
View article: Supplementary Figures from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Supplementary Figures from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma Open
Supplementary Figures S1 and S2
View article: Data from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Data from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma Open
Purpose:Fumarate hydratase–deficient renal cell carcinoma (FH-RCC) is a rare, aggressive form of RCC associated with hereditary leiomyomatosis and RCC syndrome. Evidence for systemic therapy efficacy is lacking.Experimental Design:We studi…
View article: Data from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Data from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma Open
Purpose:Fumarate hydratase–deficient renal cell carcinoma (FH-RCC) is a rare, aggressive form of RCC associated with hereditary leiomyomatosis and RCC syndrome. Evidence for systemic therapy efficacy is lacking.Experimental Design:We studi…
View article: Supplementary Tables and Figures from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Supplementary Tables and Figures from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma Open
Supplementary Tables and Figures
View article: Supplementary Tables and Figures from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Supplementary Tables and Figures from Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma Open
Supplementary Tables and Figures
View article: Ovarian cancer mutational processes drive site-specific immune evasion
Ovarian cancer mutational processes drive site-specific immune evasion Open
View article: Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer
Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer Open
View article: CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know—<i>Radiology</i> In Training
CT of Ovarian Cancer for Primary Treatment Planning: What the Surgeon Needs to Know—<i>Radiology</i> In Training Open
A 60-year-old woman presented with intermittent abdominal pain, an elevated serum CA-125 level, and an abnormal CT examination and was ultimately diagnosed with advanced-stage high-grade serous ovarian cancer. Key tumor locations on CT sca…
View article: MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy
MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy Open
View article: Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes
Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes Open
Background It is unknown how the imperfect accuracy of MRI for local staging of prostate cancer relates to oncologic outcomes. Purpose To analyze how staging discordances between MRI and histopathologic evaluation relate to recurrence and …
View article: Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes
Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes Open
High-grade serous ovarian cancer (HGSOC) is an archetypal cancer of genomic instability patterned by distinct mutational processes, intratumoral heterogeneity and intraperitoneal spread. We investigated determinants of immune recognition a…
View article: Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma
Comprehensive Molecular Characterization and Response to Therapy in Fumarate Hydratase–Deficient Renal Cell Carcinoma Open
Purpose: Fumarate hydratase–deficient renal cell carcinoma (FH-RCC) is a rare, aggressive form of RCC associated with hereditary leiomyomatosis and RCC syndrome. Evidence for systemic therapy efficacy is lacking. Experimental Design: We st…
View article: Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study
Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study Open
View article: Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings Open
Magnetic resonance imaging findings of localized prostate cancer are associated with clinically relevant long-term oncologic outcomes. Combining magnetic resonance imaging and clinicopathological data results in more accurate prognosticati…
View article: A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers
A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers Open
View article: Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers
Machine learning-based prediction of microsatellite instability and high tumor mutation burden from contrast-enhanced computed tomography in endometrial cancers Open
To evaluate whether radiomic features from contrast-enhanced computed tomography (CE-CT) can identify DNA mismatch repair deficient (MMR-D) and/or tumor mutational burden-high (TMB-H) endometrial cancers (ECs). Patients who underwent targe…
View article: NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation
NRF2 Dysregulation in Hepatocellular Carcinoma and Ischemia: A Cohort Study and Laboratory Investigation Open
Background Intermediate stage hepatocellular carcinomas (HCCs) are treated by inducing ischemic cell death with transarterial embolization (TAE) or transarterial chemoembolization (TACE). A subset of HCCs harbor nuclear factor E2-related f…
View article: A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative Open
View article: Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy Open
View article: 4:03 PM Abstract No. 197 ARID1A mutations are associated with shorter time to local progression and worse overall survival after embolization of hepatocellular carcinomas
4:03 PM Abstract No. 197 ARID1A mutations are associated with shorter time to local progression and worse overall survival after embolization of hepatocellular carcinomas Open
View article: Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer?
Does the method of primary treatment affect the pattern of first recurrence in high-grade serous ovarian cancer? Open
View article: MRI of Tumors and Tumor Mimics in the Female Pelvis: Anatomic Pelvic Space–based Approach
MRI of Tumors and Tumor Mimics in the Female Pelvis: Anatomic Pelvic Space–based Approach Open
Pelvic masses can present a diagnostic challenge owing to the difficulty in assessing their origin and the overlap in imaging features. The majority of pelvic tumors arise from gastrointestinal or genitourinary organs, with less common sit…
View article: Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease
Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease Open
View article: Primary Liver Carcinoma with Biphenotypic Differentiation: Imaging Appearances and Clinical Significance
Primary Liver Carcinoma with Biphenotypic Differentiation: Imaging Appearances and Clinical Significance Open
Poster: ECR 2019 / C-3260 / Primary Liver Carcinoma with Biphenotypic Differentiation: Imaging Appearances and Clinical Significance by: N. Long 1, I. Nikolovski2, R. Do2; 1New York, NY/US, 2New York/US
View article: Unraveling Tumor-Immune Heterogeneity in Advanced Ovarian Cancer Uncovers Immunogenic Effect of Chemotherapy
Unraveling Tumor-Immune Heterogeneity in Advanced Ovarian Cancer Uncovers Immunogenic Effect of Chemotherapy Open
In metastatic cancer, the role of heterogeneity at the tumor-immune microenvironment, its molecular underpinnings and clinical relevance remain largely unexplored. To understand tumor-immune dynamics at baseline and upon chemotherapy treat…
View article: Splenogonadal fusion
Splenogonadal fusion Open